Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jordan T. VanderBurgt has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Production and Immunogenicity of a Plant-Produced Subunit Vaccine Candidate Against Porcine Epidemic Diarrhea Virus

    by Muhammad Sufyan Tahir, Angelo Kaldis, Jordan T. VanderBurgt, Christopher P. Garnham, Hong Zhu, Doug Cossar, Rima Menassa

    Porcine epidemic diarrhea virus (PEDV) is a highly virulent enteric pathogen of swine that causes acute, contagious disease with high mortality in neonatal piglets. Conventional inactivated and live-attenuated vaccines have shown limited success in reducing mortality and controlling PEDV transmission. Recombinant subunit vaccines offer a promising alternative, and self-assembling protein scaffolds are an attractive strategy for improving antigen presentation and immunogenicity. In this study, we explored two scaffolds - tobacco mosaic virus coat protein (TMVc) and lumazine synthase from Brucella spp. (BLS) - for plant-based production of PEDV spike-derived vaccine candidates. Five antigenic regions spanning the S1 subunit were selected based on structural organization, fused to either scaffold, and transiently expressed in Nicotiana benthamiana. TMVc fusions accumulated to higher levels than BLS fusions, and TS1-G, comprised of the complete S1 subunit and a portion of S2 fused to TMVc, was selected for scale-up, purification, and immunogenicity evaluation. Purified TS1-G did not assemble into canonical TMVc nanorods but instead formed irregular multimeric aggregates. Nevertheless, TS1-G elicited a strong antigen-specific IgG response in BALB/c mice at both 3 and 30 µg doses, with higher responses observed at the 30 µg dose. These findings demonstrate that plant-produced TS1-G is immunogenic, and support further evaluation of plant-produced PEDV spike fusion proteins as subunit vaccine candidates.

  • Open Access

    Ferritin as a Nanoparticle Scaffold for Plant‐Produced Next‐Generation Subunit Vaccines

    by Jordan T. VanderBurgt, Richard Strasser, Christopher P. Garnham, Rima Menassa

    Protein nanoparticles offer an innovative approach to next‐generation subunit vaccine development by displaying antigenic sequences on the nanoparticle surface. Compared to traditional subunit vaccines, protein nanoparticle vaccines often show improved interaction with the immune system due to their particulate size and repetitive epitope display. Ferritin from Helicobacter pylori assembles into a spherical shape composed of 24 subunits that can display foreign peptides on its surface for use in vaccine development. Surface display can be achieved via genetic fusion of sequences encoding antigenic peptides to the N‐terminus of the protein. Ferritin‐based vaccine candidates have been increasingly explored through recombinant production in bacteria, insect cells, and mammalian cells; however, this protein had not been produced in plants before. We expressed ferritin from H. pylori in Nicotiana benthamiana and targeted it to the secretory pathway. We also modified ferritin to prevent glycosylation. We found this ferritin variant accumulates to over 0.2 mg/g fresh weight in plant leaves, and genetic fusion of a viral glyco‐epitope to this protein significantly increases accumulation. We determined that the epitope is efficiently glycosylated and the protein fusion assembles into characteristic nanoparticles. We found that this fusion protein shows similar iron mineralization to the unmodified ferritin, and introducing a two amino acid substitution decreased this function. This study provides the groundwork for further exploration of plant‐produced ferritin as a scaffold for vaccine development.

  • Open Access

    Design and Immunogenicity of a Nanoparticle Combination Vaccine for Salmonella in Poultry

    by Shabnam Shamriz, Angelo Kaldis, Carly A. Charron, Jordan T. VanderBurgt, Christopher P. Garnham, Moussa S. Diarra, Rima Menassa

    Salmonella enterica serovars ( Salmonella ) are common causes of bacterial gastroenteritis (salmonellosis) often associated with the consumption of poultry products. The control of Salmonella in broiler chickens is difficult because colonized birds may carry this pathogen undetected into the slaughterhouse and cause meat contamination. Poultry vaccines can mitigate colonization, and one promising production method is via plants. Iron is an essential nutrient for Salmonella; therefore, our goal was to exploit iron uptake systems as vaccine targets that could starve this pathogen of iron and thus prevent it from colonizing chickens. One challenge with this approach is that Salmonella possesses several iron acquisition proteins that are redundant in function. Therefore, we created nanoparticle‐based plant‐produced vaccine candidates against four different Salmonella iron acquisition proteins to create a multivalent vaccine that may be more effective than targeting a single protein. Extracellular antigenic peptides from each of these proteins were fused in tandem to the N‐terminus of the self‐assembling Brucella spp. lumazine synthase. These fusion constructs were then expressed in Nicotiana benthamiana plants. The resulting recombinant proteins were extracted, purified and characterized. The vaccine candidates administered individually or in combination elicited specific antibodies in mice and bound to the surface of Salmonella, indicating their potential in preventing Salmonella colonization in poultry.


  • Open Access

    Protein nanoparticles assemble in plants, display antigenic viral peptides, and produce an epitope‐specific immune response

    by Jordan T. VanderBurgt, Richard Strasser, Hong Zhu, Angelo Kaldis, Christopher P. Garnham, Rima Menassa

    Porcine reproductive and respiratory syndrome (PRRS) is one of the major diseases affecting the global swine industry. Current methods to control this viral disease are insufficient or pose safety concerns; therefore, there is a need for a safer and more effective vaccine against PRRS. In this study, we designed a chimeric nanoparticle vaccine through genetic fusion of an epitope composed of portions from two PRRS viral proteins, M and GP5, with lumazine synthase from Aquifex aeolicus . Transient expression in the leaves of Nicotiana benthamiana plants resulted in soluble levels around 0.18 mg·g −1 of plant fresh weight. This fusion protein assembles into nanoparticle structures surface‐displaying the PRRS epitope and is efficiently glycosylated with oligomannose N‐linked glycans. A mouse immunization trial was conducted using this protein as well as a previously described protein consisting of the same epitope displayed on a modified tobacco mosaic virus coat protein, and both vaccine candidates induced epitope‐specific antibodies. This study demonstrates the feasibility of protein nanoparticle‐based vaccines against PRRS produced in plants and lays the foundation for future studies to evaluate vaccine efficacy in pigs.


  • Open Access

    pTARGEX vectors: a versatile toolbox for plant-based protein expression

    by Camille Chartrand-Pleau, Emily Gallipeau-Burns, Ananya Jain, Victor Boddy, Patrick Fakhouri, Sarah Rehmani, Teagan Thomas, Michelle Drapeau, Jordan T. VanderBurgt, Arnaud Boudigou, et al.

    The ability to express heterologous proteins in specific plant tissues and subcellular compartments is critical for advancing plant-based biotechnologies and biopharming research. Here, we present the “pTARGEX” series, a versatile toolkit designed to enable targeted protein expression within the leaves and roots of plants. These vectors incorporate subcellular targeting sequences to direct proteins of interest to the apoplast (pTARGEX-APO), cytoplasm (pTARGEX-CYT), chloroplast (pTARGEX-CHL), endoplasmic reticulum (pTARGEX-ER), or vacuole (pTARGEX-VAC). Streamlining workflow, the pTARGEX vectors encode an mCherry dropout cassette with a SapI restriction enzyme site to enable red/white screening in Escherichia coli, and an eGFP reporter gene that is constitutively expressed in planta to serve as an inbuilt marker for monitoring of successful transformation. This innovative vector series offers users an accessible, versatile platform for plant-based heterologous protein production, facilitating research and applications in systems biology, synthetic biology, and plant biotechnology.


  • Open Access

    Plant production of a virus-like particle-based vaccine candidate against porcine reproductive and respiratory syndrome

    by Jordan T. VanderBurgt, Ondre Harper, Christopher P. Garnham, Susanne E. Kohalmi, Rima Menassa

    Porcine reproductive and respiratory syndrome (PRRS) is a disease leading to spontaneous abortions and stillbirths in sows and lowered life quality and expectancy in growing pigs. PRRS is prevalent worldwide and has significant economic impacts to swine industries around the globe. Co-expression of the two most abundant proteins in the viral envelope, the matrix protein (M) and glycosylated protein 5 (GP5), can produce a neutralizing immune response for the virus providing a potentially effective subunit vaccine against the disease, but these proteins are difficult to express. The goal of this research was to display antigenic portions of the M and GP5 proteins on the surface of tobacco mosaic virus-like particles. A modified tobacco mosaic virus coat protein (TMVc) was transiently expressed inNicotiana benthamianaleaves and targeted to three subcellular compartments along the secretory pathway to introduce glycosylation patterns important for M-GP5 epitope immunogenicity. We found that accumulation levels in the apoplast were similar to the ER and the vacuole. Because glycans present on plant apoplastic proteins are closest to those present on PRRSV proteins, a TMVc-M-GP5 fusion construct was targeted to the apoplast and accumulated at over 0.5 mg/g of plant fresh weight. TMVc virus-like particles self-assembled in plant cells and surface-displayed the M-GP5 epitope, as visualized by transmission electron microscopy and immunogold localization. These promising findings lay the foundation for immunogenicity and protective-immunity studies in animals to examine the efficacy of this vaccine candidate as a measure to control PRRS.